Happy to share some great news!
Fresenius Medical Care announced the launch of the Xenios console and Novalung patient kits in South Korea!
The introduction of heart and lung therapies expands Fresenius Medical Care’s portfolio in South Korea to multi-organ support. The Xenios console was approved by the Ministry of Food and Drug Safety (MFDS) in May, 2021, following the approval of the Novalung patient kits in November 2020.
Read original press release in Korean language: http://ow.ly/1jwa50GG2gv
